Quest Diagnostics Inc vs First Trust Cloud Computing ETF — how do they compare? Quest Diagnostics Inc trades at $230.97 (market cap $25.48B), while First Trust Cloud Computing ETF trades at $174.89 (market cap $3.47B). The key difference: Quest Diagnostics Inc is far larger — about 7.3× First Trust Cloud Computing ETF's market cap, and Quest Diagnostics Inc pays a 1.49% dividend while First Trust Cloud Computing ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Quest Diagnostics Inc for 56 Days and First Trust Cloud Computing ETF for 85 Days on average.
| DGX | SKYY | |
|---|---|---|
Market Cap | $25.48B | $3.47B |
Volume | 941,866 | 176,159 |
Sector | Health | — |
52-Week High | $247.45 | $174.89 |
52-Week Low | $173.49 | $104.16 |
Typical Hold Time | 56 Days | 85 Days |
Enterprise Value | $31.23B | — |
Dividend Yield | 1.49% | — |
Signals from Pluang's Aura AI — not financial advice
Quest Diagnostics (DGX) trades at $230.81, up 1.68% today, with a bullish earnings trend after beating EPS estimates for three consecutive quarters. The stock shows a mixed technical picture with a bearish overall signal but trades near key support at $228. Revenue growth accelerated to $11.04B in 2025, and the company maintains solid profitability with a 9.19% net income margin. Recent news highlights growth in consumer testing and a partnership with Apple Health, though Medicare reimbursement cuts pose a headwind.
The outlook is cautiously optimistic, supported by strong fundamentals and a consensus price target of $250 offering 8% upside. Key opportunities include demand for advanced diagnostics and AI adoption, while risks center on regulatory pressure and rising debt levels. Analyst sentiment is mixed with a slight hold bias, reflecting balanced growth prospects against near-term challenges.
SKYY (First Trust Cloud Computing ETF) trades at $170.14, down 0.37% on the day but near its 52-week high of $169.41. Technical indicators show a bullish trend with strong moving average support and neutral oscillators. The ETF benefits from strong secular trends in cloud computing and AI adoption, with recent news highlighting institutional position adjustments and positive sector momentum.
The outlook remains positive given cloud computing's growth trajectory and AI infrastructure demand. Key risks include sector concentration and market volatility. Analyst sentiment is generally favorable, though valuation metrics are not provided in current data. The ETF's diversified exposure to cloud infrastructure positions it well for continued technology adoption trends.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →